Your browser doesn't support javascript.
loading
Efficacy, Safety and Immunogenicity of MB02 (Bevacizumab Biosimilar) versus Reference Bevacizumab in Advanced Non-Small Cell Lung Cancer: A Randomized, Double-Blind, Phase III Study (STELLA).
Trukhin, Dmytro; Poddubskaya, Elena; Andric, Zoran; Makharadze, Tamta; Bellala, Ravi Shankar; Charoentum, Chaiyut; Yañez Ruiz, Eduardo P; Fulop, Andrea; Hyder Ali, Irfhan Ali; Syrigos, Kostas; Katgi, Nuran; Lopez Chuken, Yamil Alonso; Rumyana, Ilieva; Reyes-Igama, Jasmin; Costamilan, Rita de Cassia; Del Campo García, Ana; Florez, Amalia; Paravisini, Alexandra; Millan, Susana.
Afiliação
  • Trukhin D; Day Patient Facility of Dispensary and Policlinic Department, Odessa Regional Oncological Dispensary, Odessa, Ukraine.
  • Poddubskaya E; VitaMed, LLC, Moscow, Russia.
  • Andric Z; Clinical Hospital Center, Bezanijska kosa Bezanijska kosa bb, Beograd, Serbia.
  • Makharadze T; Ltd High Technology Hospital Medcenter, Batumi, Adjara, Georgia.
  • Bellala RS; Queens NRI Hospital, Visakahapatnam, India.
  • Charoentum C; Maharaj Nakorn Chiang Mai Hospital, Faculty of Medicine, Chiang Mai University, Muang, Chiang Mai, Thailand.
  • Yañez Ruiz EP; Oncology-Hematology Unit. Department of Internal Medicine. School of Medicine, Clinical Research Center SIM, University of the Frontera, Temuco, Chile.
  • Fulop A; Orszagos Koranyi Pulmonologiai Intezet, VI. Tudobelosztaly, Budapest, Hungary.
  • Hyder Ali IA; Respiratory Department, Hospital Pulau Pinang, George Town, Pinang, Malaysia.
  • Syrigos K; Department of Internal Medicine, Sotiria General Hospital for Chest Diseases, Athens, Greece.
  • Katgi N; Dr. Suat Seren Chest Diseases and Chest Surgery Training and Research Hospital, Health Sciences University, Izmir, Yenisehir, Turkey.
  • Lopez Chuken YA; Hospital Universitario "Dr. Jose Eleuterio Gonzalez" (Centro Universitario contra el Cancer), Monterrey, Nuevo Leon, Mexico.
  • Rumyana I; Plovid Department of Medical Oncology, Multiprofile Hospital for Active Treatment Central Onco Hospital OOD, Plovdiv, Bulgaria.
  • Reyes-Igama J; Baguio General Hospital and Medical Center. Baguio city, Benguet, Philippines.
  • Costamilan RC; Fundacao Universidade de Caxias do Sul, Instituto de Pesquisas Clinicas para Estudos Multicentricos, IPCEM, Caxias do Sul, Brazil.
  • Del Campo García A; mAbxience Research S.L., Madrid, Spain. ana.delcampo@mabxience.com.
  • Florez A; mAbxience Research S.L., Madrid, Spain.
  • Paravisini A; mAbxience Research S.L., Madrid, Spain.
  • Millan S; mAbxience Research S.L., Madrid, Spain.
BioDrugs ; 35(4): 429-444, 2021 Jul.
Article em En | MEDLINE | ID: mdl-33914256
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma Pulmonar de Células não Pequenas / Medicamentos Biossimilares / Neoplasias Pulmonares Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Revista: BioDrugs Assunto da revista: ALERGIA E IMUNOLOGIA / GENETICA MEDICA / TERAPEUTICA / TERAPIA POR MEDICAMENTOS Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Ucrânia
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma Pulmonar de Células não Pequenas / Medicamentos Biossimilares / Neoplasias Pulmonares Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Revista: BioDrugs Assunto da revista: ALERGIA E IMUNOLOGIA / GENETICA MEDICA / TERAPEUTICA / TERAPIA POR MEDICAMENTOS Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Ucrânia